India's Pharmaceutical Exports

Country Profile

Cyprus

Cyprus is an emerging destination for Indian pharmaceutical exports — $18.7M in FY 2025–26, with 1.7× growth over the past decade. Medicine Ingredients accounts for 68% of shipments. The compound annual growth rate since FY2015 stands at 5.0%.

🇨🇾 $18.7M · 1.7× growth since FY2015 · 5.0% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$18.7M
Exports FY2025–26 DGCIS
1.7×
Growth FY2015→2026
5.0%
CAGR FY2015→2026
68%
Medicine Ingredients Share
4
Product Categories Supplied
Cyprus is an emerging destination for Indian pharmaceutical exports — $18.7M in FY 2025–26, with 1.7× growth over the past decade. Medicine Ingredients accounts for 68% of shipments. The compound annual growth rate since FY2015 stands at 5.0%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicine Ingredients $12.8M (68.4%) Medicines $5.57M (29.8%) Surgical & Hospital Supplies $328K (1.8%) Traditional & Herbal $17K (0.1%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Cyprus in the RBI overseas direct investment dataset (2011–2026).